Stephanie Halver, a 43-year-old woman from Vancouver, Washington, faced an unexpected medical bill after receiving a breast MRI recommended by her doctor due to her elevated risk of breast cancer. Despite prior approval from her insurer, Blue Cross Blue Shield of Texas, through her employer-sponsored plan, Halver was charged more than $1,200 for the preventive scan conducted on September 26.
Halver’s higher risk stemmed from her family history—both her mother and aunt had breast cancer—and personal factors such as dense breast tissue and age. Her physician advised an annual breast MRI to supplement the standard mammogram, following a risk assessment tool that indicated a significantly increased chance of developing breast cancer. Breast MRIs provide detailed images and can detect cancers that mammograms may miss, a fact underscored by cases like actress Olivia Munn, who was diagnosed with aggressive breast cancer through an MRI despite a clear mammogram.
However, while mammograms are typically covered fully as preventive care under the Affordable Care Act (ACA), breast MRIs do not always receive the same coverage. Halver’s insurer paid only a small portion—$13.90—toward the $1,205 bill, leaving her responsible for $1,191.10, plus an additional $65.60 charge for medication used during the procedure. The cost was applied toward her $3,300 annual deductible.
Confusion around the billing arose because insurance plans are governed by guidelines from the U.S. Preventive Services Task Force (USPSTF), which does not currently recommend breast MRIs as a preventive screening for women with dense breast tissue or other risk factors without abnormalities detected on mammograms. According to the USPSTF, evidence remains insufficient to assess the balance of benefits and harms for this group. In contrast, federal guidelines from the Health Resources and Services Administration (HRSA) provide preventive coverage for additional imaging, including MRIs, when an abnormality is detected during mammography.
This discrepancy leaves many women like Halver vulnerable to substantial out-of-pocket costs. State laws in Washington and elsewhere often require insurers to cover breast MRIs, but such laws typically do not apply to self-insured employer plans, which are regulated at the federal level. Advocates warn that this patchwork regulatory environment fails to resolve the issue for women requiring preventive screening beyond mammograms.
Halver appealed the insurer’s decision, but her appeal was denied in July. She confirmed with her employer’s human resources department that while mammograms are covered as preventive screening, breast MRIs are not, resulting in her bill being subject to deductibles and cost-sharing.
Health advocates recommend that patients consider their insurance plan’s coverage policies and state laws before undergoing a breast MRI. Patient navigators at hospitals or cancer centers may assist with insurance questions and finding lower-cost options. Additionally, some community programs and national advocacy groups provide financial resources for breast cancer screening. Scheduling imaging at strategic times during the insurance year and comparing prices at freestanding imaging centers may also help reduce expenses.
As advanced breast cancer screening grows more common, the case highlights ongoing challenges in insurance coverage and the importance of clarity around preventive care benefits for at-risk individuals.